InsideArbitrage Potential Deal Alert: Ikena Oncology (IKNA) Explores Strategic Options to Maximize Shareholder Value
Ikena Oncology, Inc. (IKNA) announced that it is evaluating strategic options for both the company and its development pipeline, as it discontinues the clinical IK-930
Read More